A peer-reviewed journal that offers evidence-based clinical information and continuing education for dentists.

COVID-19 Booster Shot Targeting Omicron Gets FDA Approval


On August 31, the United States Food and Drug Administration (FDA) adjusted the Emergency Use Authorization for the Pfizer and Moderna COVID-19 vaccines to include a modified dose designed to provide protection against the Omicron BA.5 variant. This is the first revision to the vaccines since they debuted in December 2020. The US has more than 170 million doses of the booster shot, which will be available to those ages 12 and older. The US Centers for Disease Control and Prevention still needs to sign off on the shots, which should be available immediately following Labor Day weekend. Click here to read more.

Leave A Reply

Your email address will not be published.

This site uses Akismet to reduce spam. Learn how your comment data is processed.

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy